Jim Cramer Just Couldn’t Help Himself When Talking About Kimberly-Clark (KMB)’s Kenvue Acquisition

We recently published 11 Latest Stocks Jim Cramer Talked About. Kimberly-Clark Corporation (NASDAQ:KMB) is one of the stocks Jim Cramer recently discussed.

Along with OpenAI’s Amazon deal, Kimberly-Clark Corporation (NASDAQ:KMB) also made headlines after it announced that it would acquire household and personal products company Kenvue for $48.7 billion. Cramer discussed Kimberly-Clark Corporation (NASDAQ:KMB)’s CEO and the rationale behind the deal:

Copyright: jackf / 123RF Stock Photo

“But I gotta tell you, I love this deal. Okay cause where Kimberly is strong, they’re not. China. Where they’re strong, Europe, Kimberly is not. Kimberly has an understanding in data which shows that Tylenol has not been hurt by any of the problems that the government’s talked about. Remember it’s also just about pregnant women. The lawsuits, that are [inaudible], talc, to Europe, because that was carved off from JNJ. They don’t the same kind of punitive laws over there. They don’t have the huge damages. So that looked bad, it was almost like a poison pill. But it’s not that bad.

Story Continues

While we acknowledge the potential of KMB as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.

View Comments